You are here: Industry Insights > Boehringer Ingelheim

News List

Giving highest priority to ensure uninterrupted supply of medicines: Sharad Tyagi, Boehringer Ingelheim, India expresspharma
April 21, 2020
Some difficulties in distribution to stockists but will not face shortages across most locations.
Boehringer Ingelheim steps up effort with Global Support Program worldpharmanews
April 17, 2020
Boehringer Ingelheim has significantly stepped up its support to the fight against COVID-19.
Jardiance bags FDA Fast Track designation pharmatimes
March 19, 2020
The US Food and Drug Administration (FDA) has granted Boehringer Ingelheim Fast Track designation for the investigation of Jardiance (empagliflozin).
FDA Grants Fast Track Designation to Jardiance for Chronic Kidney Disease americanpharmaceuticalreview
March 16, 2020
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of Jardiance® (empagliflozin) to reduce the risk of kidney disease progression ...
Ofev® (nintedanib) approved by FDA to treat interstitial lung diseases europeanpharmaceuticalreview
March 11, 2020
The FDA has granted marketing authorisation for Ofev, as the first treatment for patients with chronic fibrosing interstitial lung diseases (ILDs).
Boehringer Ingelheim partners with Enleofen to develop first-in-class anti-IL-11 therapies for a range of fibrotic diseases worldpharmanews
January 14, 2020
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies ...
Boehringer Ingelheim, Lilly Provides Update on Jardiance Study americanpharmaceuticalreview
December 18, 2019
Boehringer Ingelheim and Eli Lilly and Company announced results from the EMPERIAL-Reduced and EMPERIAL-Preserved trials related to functional endpoints with Jardiance® (empagliflozin) ...
BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim b3cnewswire
December 04, 2019
BioMed X announced the successful completion of their first joint research project with Boehringer Ingelheim in the fields of chronic obstructive pulmonary disease (COPD) ...
Boehringer Ingelheim donates vaccines to help fight rabies biospectrumasia
September 27, 2019
Chief Executive Louis Nel of the Global Alliance for Rabies Control, which coordinates World Rabies Day, said the world is moving toward eliminating rabies deaths by 2030.
Boehringer Ingelheim opens Health Management Centre in China biospectrumasia
August 15, 2019
The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page